(7-cyclopentyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(piperidin-1-yl)methanone

ID: ALA4777302

PubChem CID: 162643397

Max Phase: Preclinical

Molecular Formula: C26H34N8O

Molecular Weight: 474.61

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1)N1CCCCC1

Standard InChI:  InChI=1S/C26H34N8O/c35-25(33-12-4-1-5-13-33)22-16-19-17-29-26(31-24(19)34(22)20-6-2-3-7-20)30-23-9-8-21(18-28-23)32-14-10-27-11-15-32/h8-9,16-18,20,27H,1-7,10-15H2,(H,28,29,30,31)

Standard InChI Key:  CQDXHMWJWCDKSB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   36.7197  -20.7090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4335  -20.2995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.4306  -19.4728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7179  -19.0634    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0075  -20.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0087  -19.4794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2284  -19.2259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7474  -19.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2264  -20.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9261  -19.8846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5144  -19.1763    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.1409  -19.0574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.8543  -19.4674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9756  -18.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4569  -17.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9776  -17.1166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1958  -17.3679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1947  -18.1892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5134  -20.5921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6963  -20.5877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2878  -21.2912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6892  -22.0033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5077  -22.0074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9249  -21.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8540  -20.2864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5625  -20.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2737  -20.2809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2680  -19.4554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5549  -19.0491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.9875  -20.6856    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.9897  -21.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6995  -21.9170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4117  -21.5041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.4095  -20.6818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6951  -20.2724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  2  0
 10 19  1  0
  3 12  1  0
 12 13  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
  7 14  1  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 13 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 13  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 27 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777302

    ---

Associated Targets(Human)

CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 474.61Molecular Weight (Monoisotopic): 474.2856AlogP: 3.72#Rotatable Bonds: 5
Polar Surface Area: 91.21Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.57CX Basic pKa: 8.86CX LogP: 3.23CX LogD: 1.76
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.58Np Likeness Score: -1.36

References

1. Shi X,Quan Y,Wang Y,Wang Y,Li Y.  (2021)  Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells.,  33  [PMID:33316409] [10.1016/j.bmcl.2020.127725]

Source